Neural Regeneration Research · 2016 · 106 citations · 33 references
MedicineNeurosciencePharmacologyMemoryNeurodegenerationNeuropharmacologyAlzheimer DiseaseCognitive ImpairmentDementia TreatmentNeurodegenerative DiseasesNeurodegenerative DisordersNeuroprotectionAlzheimer Disease NeuroprotectionNeuronal DysfunctionNeuroprotective AgentsNeuroprotective PharmacotherapyPharmacological Treatment Of Dementia
There is currently no treatment for effectively slowing the progression of Alzheimer's disease, so early prevention is very important. Numerous studies have shown that flavonoids can improve memory impairment. The present study investigated the effects of myricetin, a member of the flavonoids, on intracerebroventricular streptozotocin induced neuronal loss and memory impairment in rat models of Alzheimer's disease. Myricetin at 5 or 10 mg/kg was intraperitoneally injected into rats over 21 days. Control rats were treated with 10 mL/kg saline. Behavioral test (the shuttle box test) was performed on day 22 to examine learning and memory in rats. Immediately after that, hematoxylin-eosin staining was performed to observe the morphological change in hippocampal CA3 pyramidal neurons. Myricetin greatly increased the number of hippocampal CA3 pyramidal neurons and improved learning and memory impairments in rats with Alzheimer's disease. These findings suggest that myricetin is beneficial for treatment of Alzheimer's disease.
33
Neurogenesis in the adult human hippocampus
Peter S. Eriksson, Ekaterina Perfilieva, Thomas Björk‐Eriksson et al. · Nature Medicine · 1998 · 6.3K citations
The neuroprotective potential of flavonoids: a multiplicity of effects
David Vauzour, Katerina Vafeiadou, Ana Rodriguez‐Mateos et al. · Genes & Nutrition · 2008 · 550 citations · Full text
Medicine, Neuroscience, Pharmacology +12